CLINICAL_TRIALS
trial_result
· 2022-09-29
Clinical Trial Update: Neuroinflammation in Hypertension Study [Phase 3]
Summary
Phase 3 clinical trial update on neuroinflammation in hypertension, focusing on resistant hypertension; status unspecified.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Royal Perth Hospital | Conditions: Resistant Hypertension | Phase 3 | Status: UNKNOWN